Home > Cannabis & Mental Health > Cannabis & Psychosis

Cannabis & Psychosis: What the Evidence Shows

A Research-Based Analysis of Cannabis-Related Psychosis Risk
By Dr. Ryan S. Sultan, Assistant Professor of Clinical Psychiatry
Columbia University Irving Medical Center
NIH NIDA-Funded Cannabis & Mental Health Researcher

Contents:
The Key Evidence | How Big Is the Risk? | How Cannabis Causes Psychosis | Why Adolescents Are Most Vulnerable | Acute vs. Chronic Psychosis | The Potency Factor | Who Is Most at Risk | Cannabis and Schizophrenia | What To Do | FAQ

The Key Evidence

The link between cannabis and psychosis is supported by some of the largest and most rigorous studies in psychiatric epidemiology. This is not preliminary or controversial — it is a well-established finding replicated across multiple countries, study designs, and populations.

The Kaiser Permanente Study (2026)

The largest and most recent study, published in JAMA Health Forum, followed 463,396 adolescents aged 13-17 at Kaiser Permanente Northern California from 2016-2023:

Young-Wolff KC, et al. JAMA Health Forum. 2026;7(2):e256839.

Key details: These associations remained significant even after adjusting for sex, race/ethnicity, neighborhood deprivation, insurance, alcohol use, and other substance use. The mean time from first cannabis report to psychiatric diagnosis was approximately 2 years. Sensitivity analyses excluding adolescents with any psychiatric history at baseline yielded nearly identical results (psychotic AHR 1.99).

The age effect was striking: For depression, the hazard ratio was 1.78 for ages 13-15, 1.35 for ages 16-17, and decreased to non-significant by ages 21-25. Cannabis is most dangerous for the youngest users.

Sultan et al. (2023) — Nondisordered Cannabis Use

My research team's study of 68,263 U.S. adolescents (JAMA Network Open) showed that even nondisordered cannabis use — use that does NOT meet criteria for addiction — was associated with significantly elevated risk of adverse outcomes including depression (aOR 1.86), suicidal ideation (aOR 2.08), and cognitive impairment (difficulty concentrating aOR 1.81).

This is critical: you do not need to be addicted to cannabis for it to affect your mental health.

The Lancet Psychiatry (2019) — Di Forti et al.

A study across 11 European cities found that daily use of high-potency cannabis (>10% THC) was associated with nearly 5 times the risk of a first psychotic episode compared to non-use. The study estimated that high-potency cannabis could account for 12% of all first-episode psychosis cases across Europe — and as high as 30% in London and 50% in Amsterdam.

How Big Is the Risk?

Risk is dose-dependent — the more you use, and the higher the potency, the greater the risk.

Context: The baseline lifetime risk of developing a psychotic disorder is approximately 3%. If cannabis doubles that risk, it becomes 6%. This means that for every 100 adolescent cannabis users, approximately 3 additional people will develop a psychotic disorder who would not have otherwise. At a population level — with millions of adolescents using cannabis — this translates to thousands of preventable cases.

How Cannabis Causes Psychosis: The Neuroscience

THC disrupts brain systems that are directly involved in reality testing, perception, and thought organization.

The Dopamine Hypothesis

Psychosis is fundamentally linked to excess dopamine signaling in the mesolimbic pathway. THC increases dopamine release in this pathway — the same neurochemical abnormality seen in schizophrenia. In individuals with genetic vulnerability, repeated THC-driven dopamine surges can push the system past a tipping point.

Endocannabinoid System Disruption

The brain's endocannabinoid system helps regulate neurotransmitter release, including dopamine and glutamate. THC overwhelms this regulatory system, disrupting the fine-tuned balance that maintains coherent perception and thought. As Hurd (2025) describes in translational research, adolescent cannabis exposure causes lasting changes to the endocannabinoid system that cannot be fully reversed because they occur during critical developmental windows.

The Developing Brain

The brain continues developing until approximately age 25. During adolescence, the prefrontal cortex — responsible for judgment, reality testing, and thought organization — is the last region to mature. The endocannabinoid system plays a critical role in guiding this development. When THC floods CB1 receptors at levels far beyond what the body's own cannabinoids produce, the brain responds by shutting down receptors, leaving fewer available for the normal developmental work they are supposed to do.

The consequences are structural and measurable:

• The hippocampus (memory center) physically shrinks
• The prefrontal cortex must recruit more neurons to accomplish the same tasks a non-user's brain handles efficiently
• White matter (the insulation that allows signals to travel quickly between brain regions) is damaged or laid down incorrectly
• The reward system gets hijacked so that normal sources of satisfaction no longer register

In adults, the brain largely recovers after stopping cannabis use. In adolescents, it does not, because the drug was present during construction. The pruning that happened too early cannot be reversed. The connections that were never properly formed do not appear later.

Why Adolescents Are Most Vulnerable

Every major study shows the same pattern: the younger you start using cannabis, the higher your risk of psychosis.

The Young-Wolff (2026) study demonstrated this directly: the hazard ratio for depression was 1.78 at ages 13-15, declining to 1.35 at ages 16-17, 1.21 at ages 18-20, and not significant by ages 21-25. The same age-dependent pattern appeared across all psychiatric outcomes.

The Dunedin Longitudinal Study (Meier et al., 2012, PNAS) followed 1,037 individuals from birth to age 38 and found that persistent cannabis users who started as teenagers lost an average of 8 IQ points between age 13 and age 38 — and quitting did not restore those points. Adult-onset users showed no comparable decline. Eight points is the difference between the 50th percentile and the 29th.

The biological reason: The brain's construction is coordinated by the endocannabinoid system, which produces natural cannabinoids that bind to CB1 receptors. This system exists to guide brain development — not to get people high. THC hijacks this construction process. In males in particular, this hijacking significantly increases the risk of psychosis, with cannabis use roughly doubling the odds of developing a psychotic disorder by young adulthood.

Acute vs. Chronic Psychosis

Acute Cannabis-Induced Psychosis

Symptoms: Paranoia, hallucinations (hearing or seeing things), delusions (fixed false beliefs), disorganized thinking, agitation. Can occur during or shortly after cannabis use, particularly with high-THC products.

Duration: Typically resolves within hours to days after stopping cannabis use. Most cases resolve within a week with abstinence.

Treatment: Cessation of cannabis use, supportive care, and sometimes short-term antipsychotic medication.

The Conversion Problem

Approximately 50% of individuals who experience cannabis-induced psychosis go on to develop a permanent psychotic disorder. This is one of the highest conversion rates of any substance-induced psychosis. It means that a cannabis-related psychotic episode is not just an acute event — it may be the first manifestation of a chronic illness.

The median time from cannabis-induced psychosis to diagnosis of a schizophrenia-spectrum disorder is approximately 3.1 years (Starzer et al., American Journal of Psychiatry, 2018).

Chronic Psychotic Disorders

For those who develop a chronic condition, the diagnosis is typically schizophrenia or schizoaffective disorder. These are lifelong conditions requiring ongoing treatment with antipsychotic medications, therapy, and psychosocial support. Early intervention improves outcomes, but the condition does not resolve.

The Potency Factor

Higher-potency cannabis carries disproportionately higher psychosis risk. This is not a linear relationship — it is exponential.

The Di Forti et al. (2019) study found that while any cannabis use increased psychosis risk, daily use of high-potency cannabis (>10% THC) was associated with a nearly 5-fold increase in odds of first-episode psychosis. Low-potency use carried a much smaller risk.

This matters enormously in the current market:

• Average THC in dispensary flower: 15-25%
• Concentrates (dabs, wax, shatter): 60-90% THC
• Vape cartridges: 80-95% THC
• 1990s marijuana for comparison: 3-4% THC

A teenager using a vape cartridge at 85% THC is getting a fundamentally different pharmacological exposure than someone who smoked a joint in 1995. The psychosis risk data from the older era simply does not apply.

Who Is Most at Risk?

Cannabis-related psychosis risk is not equal for everyone. These factors multiply risk:

The most vulnerable profile: A male adolescent with a family history of schizophrenia who begins daily use of high-potency concentrates before age 16. This individual has the highest known risk of cannabis-related psychotic disorder.

Cannabis and Schizophrenia: The Debate

Does cannabis cause schizophrenia, or do people predisposed to schizophrenia use cannabis?

This has been one of the most debated questions in psychiatric research. The current scientific consensus is: both are true, and they are not mutually exclusive.

• Cannabis is a causal risk factor — it increases the probability of developing schizophrenia, particularly in genetically vulnerable individuals. The evidence for causality includes dose-response relationships, temporal precedence (use precedes onset), biological plausibility, and consistency across studies.
• People with schizophrenia liability are more likely to use cannabis — the "self-medication" hypothesis has some support, though the evidence for cannabis as a trigger is stronger than the evidence for reverse causation.
• Gene-environment interaction — cannabis may "unmask" schizophrenia in those who carry genetic risk, who might otherwise never develop the full disorder, or might develop it later in life.

The most compelling evidence comes from population-level studies showing that as cannabis potency and use rates have increased, first-episode psychosis rates have also increased in young people — a pattern difficult to explain by genetics alone.

A practical analogy: Not everyone who smokes cigarettes gets lung cancer, and some people get lung cancer without smoking. But cigarettes are a major causal risk factor. The same framework applies to cannabis and psychosis.

What To Do With This Information

If You Are a Parent

• Delay onset: The single most protective factor is delaying cannabis use until after age 25, when brain development is complete
• Talk about potency: Today's cannabis is not the cannabis you may have used. Concentrates and vapes are pharmacologically different products
• Know the signs of psychosis: Social withdrawal, paranoid thinking, hearing voices, disorganized speech, declining functioning
• Family history matters: If psychosis or schizophrenia runs in your family, cannabis use carries significantly elevated risk for your child

If You Use Cannabis

• Lower potency = lower risk: If you choose to use, lower-THC products carry less risk than concentrates or high-potency flower
• Frequency matters: Occasional use carries less risk than daily use
• Know your family history: If psychosis or schizophrenia runs in your family, the safest choice is not using cannabis at all
• Monitor for warning signs: Increasing paranoia, feeling like people are watching you, hearing things others don't, unusual beliefs
• If you experience psychotic symptoms, stop using immediately and seek psychiatric evaluation

If You Are Experiencing Psychotic Symptoms

• Stop cannabis use immediately
• Seek psychiatric evaluation as soon as possible — early intervention significantly improves outcomes
• Do not wait to see if symptoms resolve on their own — given the 50% conversion rate, professional evaluation is critical

Frequently Asked Questions

Can one-time marijuana use cause psychosis?

Rarely, but yes. A single exposure to high-potency THC can trigger acute psychotic symptoms in vulnerable individuals, particularly those with genetic predisposition. This is more common with concentrates, edibles (where dosing is unpredictable), and high-potency vapes.

Does CBD protect against THC-induced psychosis?

There is some evidence that CBD may partially counteract THC's psychotogenic effects. However, most commercial cannabis products today have been bred for high THC and low CBD — the opposite of what would be protective. Do not rely on CBD content as a safeguard against psychosis.

Is cannabis-related psychosis increasing?

Yes. Emergency department visits for cannabis-related psychosis have increased significantly in recent years, particularly in states with legalization and access to high-potency products. This aligns with what the pharmacological data would predict.

If I've used cannabis without psychosis, am I safe?

Past tolerance does not guarantee future safety. Psychosis can develop after years of use, particularly as frequency or potency increases. The mean time from first cannabis report to psychotic disorder diagnosis in the Young-Wolff study was approximately 2 years.

Does using marijuana just once a week matter?

Risk increases with frequency, but any regular use carries some elevated risk. Weekly use carries less risk than daily use, but more than occasional use. The relationship is dose-dependent.